Fennec Pharmaceuticals (FENC) vs Scribe Therapeutics (SCTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Fennec Pharmaceuticals is the larger company by market cap ($372.8 million vs $364.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FENC | SCTX |
|---|---|---|
| Share price | $10.63 | $19.23 |
| Market cap | $372.76M | $364.06M |
| 1-day change | +2.61% | +9.45% |
| YTD return | +38.05% | — |
| 1-year return | +15.29% | — |
| 5-year return | +15.67% | — |
| Forward P/E | 11.21 | — |
| EPS (TTM) | $-0.12 | $-3.84 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.25 | $39.60 |
| 52-week low | $5.65 | $13.50 |
| Distance from 52-week high | -19.77% | -51.44% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +66.23% | +196.41% |
| Average volume | 193.13K | 357.40K |
| Shares outstanding | 35.07M | 18.93M |
| Employees | 35 | 82 |
| Sector | Health Care | Healthcare |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Fennec Pharmaceuticals in Health Care and Scribe Therapeutics in Healthcare.
About Fennec Pharmaceuticals
FENC stock →Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 35 employees
About Scribe Therapeutics
SCTX stock →Scribe Therapeutics Inc. operates as a clinical-stage biotechnology company, focuses on research and developing genetic medicines using CRISPR-based tools to address the root cause of diseases, with a primary focus on cardiometabolic conditions in the United States.
Healthcare · Biotechnology · 82 employees
FENC vs SCTX FAQ
Which is bigger, Fennec Pharmaceuticals or Scribe Therapeutics?
Fennec Pharmaceuticals (FENC) is larger, with a market capitalization of $372.76M compared with $364.06M for Scribe Therapeutics (SCTX).
Are Fennec Pharmaceuticals and Scribe Therapeutics in the same industry?
No. Fennec Pharmaceuticals is in the Health Care sector, while Scribe Therapeutics is in Healthcare.